Covered recipient · General Payments record
MARY J GURA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$2,218.37
- Reported across 118 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $283.67 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exeltis, USA Inc. | $102.10 | 5 |
| Astellas Pharma US Inc | $68.84 | 4 |
| Axsome Therapeutics, Inc. | $33.63 | 2 |
| ABBVIE INC. | $23.68 | 1 |
| PFIZER INC. | $14.31 | 1 |
| Biogen, Inc. | $13.95 | 1 |
| Exact Sciences Corporation | $13.63 | 1 |
| SHIELD THERAPEUTICS INC | $13.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.68 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107265649 | CMS |
| Astellas Pharma US Inc | $16.45 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139474482 | CMS |
| Astellas Pharma US Inc | $15.75 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139486128 | CMS |
| Astellas Pharma US Inc | $17.24 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139484438 | CMS |
| Astellas Pharma US Inc | $19.40 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139492546 | CMS |
| Axsome Therapeutics, Inc. | $15.49 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148390296 | CMS |
| Axsome Therapeutics, Inc. | $18.14 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148390298 | CMS |
| Biogen, Inc. | $13.95 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104854946 | CMS |
| Exact Sciences Corporation | $13.63 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114470011 | CMS |
| Exeltis, USA Inc. | $22.15 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150013073 | CMS |
| Exeltis, USA Inc. | $19.11 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150013075 | CMS |
| Exeltis, USA Inc. | $22.26 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150013077 | CMS |
| Exeltis, USA Inc. | $15.72 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150013079 | CMS |
| Exeltis, USA Inc. | $22.86 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150013081 | CMS |
| PFIZER INC. | $14.31 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131308754 | CMS |
| SHIELD THERAPEUTICS INC | $13.53 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150135089 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.